Neuroleptic Malignant Syndrome Requiring Neurological Intensive Care Unit Follow-up: Review with Nine Cases | Zendy

Nazlı Gamze Bülbül | Zendy; Yaprak Seçıl | Zendy; Yeşim Beckmann | Zendy; Tülay Kurt İncesu | Zendy; Galip Akhan | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Neuroleptic Malignant Syndrome Requiring Neurological Intensive Care Unit Follow-up: Review with Nine Cases

Author(s) -

Nazlı Gamze Bülbül,

Yaprak Seçıl,

Yeşim Beckmann,

Tülay Kurt İncesu,

Galip Akhan

Publication year - 2014

Publication title -

türk yoğun bakım derneği dergisi/türk yoğun bakım dergisi

Language(s) - English

Resource type - Journals

eISSN - 2146-6416

pISSN - 2147-267X

DOI - 10.4274/tybdd.18189

Subject(s) - neuroleptic malignant syndrome , intensive care unit , medicine , intensive care medicine , pediatrics

Neuroleptic malignant syndrome (NMS) is a rare but life-threatening clinical manifestation induced by neuroleptic medication. Although NMS is regarded as a psychiatric diagnosis, its treatment requires a systematic approach and thus intensive care follow-up. In this paper, we report nine cases with NMS followed up in our Neurology Intensive Care Unit over the last three years

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research